002626.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 002626.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Xiamen Kingdomway Group Co. engages in the research, development, manufacture and distribution of nutrition enhancers and bio-medical products. The company is headquartered in Xiamen, Fujian and currently employs 2,409 full-time employees. The company went IPO on 2011-10-28. The firm mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The firm distributes its products within domestic market and to overseas markets.